![]() |
|
|
Vol. 26, Issue 8, 795-801, August 1998
Institute of Chemical Toxicology, Wayne State University (M.R.-M.,
K.R., T.A.K.), and
Department of Pharmacology and Toxicology,
University of Alabama at Birmingham (C.N.F.)
Xenobiotics that induce the cytochromes P450 also produce changes
in rat hepatic sulfotransferase (SULT) gene expression. In the present
study, male Sprague-Dawley rats were treated for 3 consecutive days
with doses of phenobarbital (PB) that induce cytochrome P450 2B1/2
expression. The effects of PB treatment on hepatic aryl SULT (SULT1)
and hydroxysteroid SULT (SULT2) mRNA and immunoreactive protein levels
and on mRNA expression of individual SULT1 and SULT2 enzyme isoforms
were characterized. PB suppressed SULT1A1 mRNA levels, increased the
expression of the SULT-Dopa/tyrosine isoform, and did not produce
significant changes in SULT1C1 and SULT1E2 mRNA expression. In rats
injected with the highest test dose of PB (100 mg/kg), hepatic SULT1A1
mRNA levels were decreased to ~42% of control levels and
SULT-Dopa/tyrosine mRNA levels were increased to ~417% of
vehicle-treated control levels. Like the SULT1 subfamily, individual
members of the SULT2 gene subfamily were differentially affected by PB
treatment. PB (35, 80, and 100 mg/kg) suppressed SULT20/21 mRNA
expression to ~61, ~30, and ~41% of vehicle-treated control
levels, respectively. In contrast, SULT60 mRNA levels were increased to
~162% of control levels and SULT40/41 mRNA levels were increased to
~416% of vehicle-treated control levels in rats treated with 100 mg/kg PB. These studies support a complex role for PB-mediated effects
on the SULT multigene family in rat liver. Because individual SULT1 and
SULT2 enzyme isoforms are known to metabolize a variety of potentially
toxic substrates, varied responses to PB among members of the SULT
multigene family might have important implications for xenobiotic
hepatotoxicity.
This article has been cited by other articles:
![]() |
Y. Alnouti and C. D. Klaassen Regulation of Sulfotransferase Enzymes by Prototypical Microsomal Enzyme Inducers in Mice J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 612 - 621. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Maiti and G. Chen Tamoxifen Induction of Aryl Sulfotransferase and Hydroxysteroid Sulfotransferase in Male and Female Rat Liver and Intestine Drug Metab. Dispos., May 1, 2003; 31(5): 637 - 644. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Duanmu, T. A. Kocarek, and M. Runge-Morris Transcriptional Regulation of Rat Hepatic Aryl Sulfotransferase (SULT1A1) Gene Expression by Glucocorticoids Drug Metab. Dispos., August 1, 2001; 29(8): 1130 - 1135. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. H. Coughtrie and L. E. Johnston Interactions between Dietary Chemicals and Human Sulfotransferases{---}Molecular Mechanisms and Clinical Significance Drug Metab. Dispos., April 1, 2001; 29(4): 522 - 528. [Abstract] [Full Text] |
||||
![]() |
M. Runge-Morris, W. Wu, and T. A. Kocarek Regulation of Rat Hepatic Hydroxysteroid Sulfotransferase (SULT2-40/41) Gene Expression by Glucocorticoids: Evidence for a Dual Mechanism of Transcriptional Control Mol. Pharmacol., December 1, 1999; 56(6): 1198 - 1206. [Abstract] [Full Text] |
||||